Detection of mutated c-Ki-ras in the bile of patients with pancreatic cancer

Anticancer Research

Volumn 17, Issue 2 A, 1997, Pages 795-801

  Abbruzzese, James L ^a   Evans, Douglas B ^a   Raijman, Isaac ^a   Larry, Lillie ^a   King, Theresa ^a   Leach, Steven D ^a   Frazier, Marsha L ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Diagnosis; K ras; Pancreatic cancer

Indexed keywords

DNA;

ADVANCED CANCER; ALLELE; ARTICLE; BILE; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; CYTOLOGY; DNA DETERMINATION; EARLY DIAGNOSIS; GENE AMPLIFICATION; GENE MUTATION; HUMAN; HUMAN CELL; ONCOGENE K RAS; PANCREAS CANCER; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK;

BILE; DNA, NEOPLASM; GENES, RAS; HUMANS; MUTATION; PANCREATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0030994819     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Sidransky D, Von Eschenbach A, Tsai YC, et al: Identification of p53 gene mutations in bladder cancers and urine samples. Science 252:706-709, 1991.
2. Sidransky D, Tokino T, Hamilton SR, et al: Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science 256: 102-105, 1992.
3. Tada M, Omata M, Kawai S, et al: Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma. Cancer Res 53: 2472-2474, 1993.
4. Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N, and Perucho M: Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 53: 549-554, 1988.
5. Smit VT, Boot AJ, Smits AM, Fleuren GJ, Cornelisse CJ, and Bos JL: c-Ki-ras codon 12 mutations occur very frequently in pancreatic adenocarcinomas. Nucleic Acids Res 16: 7773-7782, 1988.
6. Masson P and Andren-Sandberg A: Crude isolation of DNA from unselected human pancreatic tissue and amplification by the polymerase chain reaction of Ki-ras oncogene to detect point mutations in pancreatic cancer. Acta Oncologica 31: 421-424, 1992.
7. Shibata D, Almoguera C, Forrester K, et al: Detection of c-K-ras mutations in fine needle aspirates from human pancreatic adenocarcinomas. Cancer Res 50: 1279-1283, 1990.
8. Urban T, Ricci S, Grange J-D, et al: Detection of c-Ki-ras mutation by PCR/RFLP analysis and diagnosis of pancreatic adenocarcinomas. Journal Natl Cancer Inst 85: 2008-2012, 1993.
9. Berthelemy P, Bouisson M, Vaysse N, Rumeau JL, Pradayrol L: Identification of K-ras mutations in pancreatic juice in the early diagnosis of pancreatic cancer. Ann Intern Med 123: 188-191, 1995.
10. Feron ER. c-Ki-ras gene mutation as a pathogenetic and diagnostic marker in human cancer. Journal Natl Cancer Inst 85: 1978-1980, 1993.
11. Fujii H. Egami H, Chaney W, Pour P, and Pelling J: Pancreatic ductal adenocarcinomas induced in Syrian hamsters by N-nitrosobis (2-oxopropyl) amine contain a c-Ki-ras oncogene with a point-mutated codon 12. Molec Carcinogenesis 3: 296-301, 1990.
12. Cerny WL, Mangold KA, Scarpelli DG: c-Ki-ras mutation is an early event in pancreatic duct carcinogenesis in the Syrian golden hamster. Cancer Res 52: 4507-4513, 1992.
13. Yanagisawa A, Ohtake K, Ohashi K: Frequent c-Ki-ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation. Cancer Res 53: 953-956, 1993.
14. Caldas C, Hahn SA, Hruban RH, Redston MS, Yeo CJ, and Kern SE: Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia. Cancer Res 54: 3568-3573, 1994.
15. Sherḿan S: ERCP and endoscopic sphincterotomy-induced pancreatitis. Am J Gastroenterol 89: 303-305, 1994.
16. Lowenfels AB, Maisonneuve P, Cavallini G, et al Pancreatitis and the risk of pancreatic cancer. New Engl J Med 328: 1433-1437, 1993.
17. Ekbom A, Mclaughlin JK, Karlsson B-M, et al: Pancreatitis and pancreatic cancer: A population-based study. Journal Natl Cancer Inst 86: 625-627, 1994.
18. Kahn SM, Jiang W, Culbertson TA, et al Rapid and sensitive nonradioactive detection of mutant c-Ki-ras genes via "enriched" PCR amplification. Oncogene 6: 1079-1083, 1991.
19. Chen J and Viola MV. A method to detect ras point mutautions in small subpopulations of cells. Anal Biochem 195: 51-56, 1991.
20. Levi S, Urbano-Ispizua A, Gill R, et al Multiple c-Ki-ras codon mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique. Cancer Res 51: 3497-3502, 1991.
21. Hruban RH, Van Mansfield AD, Offerhaus GJ, et al K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am J Path 143: 545-554, 1993.
22. Evans DB, Frazier ML, Charnsangavej C, Katz RL, Larry L, Abbruzzese JL: Molecular diagnosis of exocrine cancer of the pancreas using a percutaneous technique. Annals of Surgical Oncol 3: 241-246, 1996.
23. Danes BS and Lynch HT. A familial aggregation of pancreatic cancer: An in vitro study. JAMA 247: 2798-2802, 1982.
24. Lynch HT, Fusaro L, Smyrk TC, Watson P, Lanspa S, and Lynch JF: Medical genetic study of eight pancreatic cancer-prone families. Cancer Invest 13: 141-149, 1995.
25. Denko NC, Giaccia AJ, Stringer JR, and Stambrook PJ: The human Ha-ras oncogene induces genomic instability in murine fibroblasts within one cell cycle. Proc Natl Acad Sci USA 91: 5124-5128, 1994.
26. Han H-J, Yanagasawa A, Kato Y, Park J-G, and Nakamura Y: Genetic instability in pancreatic cancer and poorly differentiated type of gastric cancer. Cancer Res 53: 5087-5089, 1993.
27. Kim NW, Piatyszek MA, Prowse KR, et al Specific assocoaition of human telomerase activity with immortal cells and cancer. Science 266:2011-2015, 1994.
28. Evans D, Zhang L, Larry L, Abbruzzese J, Chiao P: The use of telomerase activity for the early diagnosis of pancreatic cancer. Program of the Pancreas Club, 30th Annual Meeting 30: 62, 1996.